CompanyHealthConsumer
Loyal
Loyal is a San Francisco clinical-stage veterinary biotech developing the first FDA-track drugs designed to extend the healthy lifespan of dogs. Its lead candidate, LOY-002, is a beef-flavored daily pill for senior dogs that targets metabolic dysfunction in aging. In 2023 it became the first company to receive an FDA acceptance that a drug can be developed to extend lifespan itself - in any species.
2020Founded
San FranciscoHQ
$100MSeries C
dog longevitycanine healthspanveterinary biotechgerosciencefda conditional approvalloy-002
